Cells containing Meflin play a role in restraining the progression of pancreatic cancer and could lead to new therapies against the disease.
List view / Grid view
Rachael Harper (Drug Target Review)
Filter the results
Researchers have developed CRISPR-Cas13 enzyme-based technology that can be programmed to both detect and destroy RNA-based viruses in human cells.
A technique to 'trick' bacteria into revealing pores in their cell walls has been developed and targeting these could make antibiotics more effective.
A new platform has the potential to better understand what dictates the invasive behaviour of brain tumours.
A genetic mutation that causes idiopathic pulmonary fibrosis has been identified and could lead to a new therapeutic approach to treating the disease.
A new algorithm has been developed which personalises which cancer mutations are best targets for immunotherapy.
A new study has shown the possibility of using RNA splicing as a potential molecular target for Alzheimer's disease.
Gene therapy for the treatment of Duchenne muscular dystrophy has safely stopped the muscle deterioration associated with the disease.
New protein-painting technology could lead to developing cancer immunotherapy medicines that can be administered as a pill.
A world-first compound that can keep cells alive and functioning in a healthy state could be revolutionary for medical emergencies.
Disruption of the MFF-VDAC1 complex could lead to a potential therapeutic target for cancer.
New research provides insights into how cancers can arise when DNA polymerase delta is not functioning properly.
New antibiotics could be designed by discovering the mechanism a weapon bacteria uses to vanquish their competitors.
A new study has shown that it is possible to specifically conduct the fate of tissue cells by using visible light.
Researchers have shown that a monoclonal antibody prevents viruses from fusing with cell membranes to gain entry.